Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease

Recently, there has been an increasing interest in the therapeutic efficacy of RAS inhibitors (RASi) in patients with non-alcoholic fatty liver disease (NAFLD) because they may reduce oxidative stress, inflammatory markers, and enhanced fibrosis. An objective of this study was to investigate the rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kwang Min, Roh, Ji-Hye, Lee, Sangjin, Yoon, Jeong-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858633/
https://www.ncbi.nlm.nih.gov/pubmed/33536442
http://dx.doi.org/10.1038/s41598-021-81959-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858633/
https://www.ncbi.nlm.nih.gov/pubmed/33536442
http://dx.doi.org/10.1038/s41598-021-81959-1

Ejemplares similares